In Vivo Characterization of Synthetic Cannabidiol Analogs for Seizure Suppression in Zebrafish
Abstract Epilepsy affects over 70 million people worldwide, nearly 20% of whom experience pharmacoresistant forms, particularly in pediatric populations. Cannabidiol…